A proof of concept Phase IIb efficacy trial to evaluate the protective efficacy of a booster MVA85A vaccination administered to BCG primed infants in the Western Cape. (360G-Wellcome-084785_B_08_Z)
Funding Organization
£317,904
Recipient Organization
Do not Publish
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 317904 |
| Applicant Surname | McShane |
| Approval Committee | Innovations Strategy Panel |
| Award Date | 2011-12-20T00:00:00+00:00 |
| Financial Year | 2011/12 |
| Grant Programme: Title | Strategic Award - Innovations |
| Internal ID | 084785/B/08/Z |
| Lead Applicant | Prof Helen McShane |
| Partnership Value | 317904 |
| Planned Dates: End Date | 2012-05-31T00:00:00+00:00 |
| Planned Dates: Start Date | 2011-12-01T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | South East |